Tele: 561.316.3330
Breaking Medical Device News

Monday, September 27, 2021
HomeMARKET REPORTSVessel Sealing Devices Global Market Insights to 2025

Vessel Sealing Devices Global Market Insights to 2025

Increasing Number of Surgical Procedures is Driving Growth

October 21, 2020

The vessel sealing devices market studied was projected to grow with a CAGR of nearly 5.6% over the forecast period. The major factors attributing to the growth of the market are the increasing number of invasive surgical processes and technological advancement in medical devices.

Furthermore, the growing demand for reliable and efficient technologies during surgeries to decrease blood loss and infection rates and reduce operative time is the major reason for the market growth. Rising investments in the surgical instruments by the hospitals and government initiatives are boosting the market. However, the high cost of the instruments involved and the complications arising after using the devices are the major drawbacks of the market growth.

Key Market Trends

The laparoscopic segment accounted for major share of the market in the forecast period.

  • Laparoscopy, is a surgical diagnostic method used to analyze the organs inside the abdomen. It’s a minimally invasive procedure that requires only small incisions. Laparoscopy uses an instrument called a laparoscope to look at the abdominal organs. Vessel sealing devices are the major part of the laparoscopic surgeries that are performed.
  • The major factors driving the growth of the segment are the increasing awareness of the advantages of laparoscopic surgeries over the open surgeries and an increasing number of laparoscopic surgeries worldwide.

North America Dominates the Market and Expected to do Same in the Forecast Period

North America is expected to dominate the overall vessel sealing devices market, throughout the forecast period. The largest share is mainly due to presence of key players and increase in per capita healthcare spending and expansion in the investment made by the major market players in the region. Furthermore, growing awareness among the population to the advantages of the surgeries with such advanced technology. High adoption of surgical procedures with advanced energy in the United States, increase in the number of approvals for new devices by the FDA, and rise in the fraction of minimally invasive surgical procedures performed in the United States subsidize to North America’s high market share in the market.

Competitive Landscape

The vessel sealing devices market is moderately competitive and consists of several major players. Some of the market players are Medtronic, B. Braun Melsungen AG, Erbe Medical India Pvt Ltd, Olympus Corporation, Ethicon US, LLC (Johnson and Johnson), Boston Scientific Corporation, Symmetry Surgical, Inc., CONMED Corporation, and Bolder Surgical Holdings, Inc.

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

Key Topics Covered:


1.1 Study Deliverables

1.2 Study Assumptions

1.3 Scope of the Study




4.1 Market Overview

4.2 Market Drivers

4.2.1 Increasing Number of Surgical Procedures

4.2.2 Technological Advancements in Vessel Sealing Devices

4.3 Market Restraints

4.3.1 Complications of the Vessel Sealing Devices

4.3.2 High Cost of Surgeries

4.4 Porter’s Five Forces Analysis

4.4.1 Threat of New Entrants

4.4.2 Bargaining Power of Buyers/Consumers

4.4.3 Bargaining Power of Suppliers

4.4.4 Threat of Substitute Products

4.4.5 Intensity of Competitive Rivalry


5.1 By Product

5.1.1 Generators

5.1.2 Instruments

5.1.3 Accessories

5.2 By Application

5.2.1 General Surgery

5.2.2 Laparoscopic Surgery

5.3 By End User

5.3.1 Hospitals

5.3.2 Ambulatory Surgical Centers

5.3.3 Other End Users

5.4 By Geography

5.4.1 North America United States Canada Mexico

5.4.2 Europe Germany United Kingdom France Italy Spain Rest of Europe

5.4.3 Asia-Pacific China Japan India Australia South Korea Rest of Asia-Pacific

5.4.4 Middle-East and Africa GCC South Africa Rest of Middle-East and Africa

5.4.5 South America Brazil Argentina Rest of South America


6.1 Company Profiles

6.1.1 Medtronic PLC

6.1.2 B Braun Melsungen AG

6.1.3 Erbe Medical India Pvt. Ltd

6.1.4 Olympus Corporation

6.1.5 Ethicon US LLC (Johnson & Johnson)

6.1.6 Boston Scientific Corporation

6.1.7 Symmetry Surgical Inc.

6.1.8 OmniGuide Holdings Inc.

6.1.9 CONMED Corporation

6.1.10 Bolder Surgical Holdings Inc.


More on this here.

Medical Device News Magazine
Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Stay Connected


Don't Miss

ProSomnus® Sleep Technologies Adds John E. Remmers, MD, to Leadership Team

Dr. John E. Remmers will provide expert medical and strategic guidance on a range of initiatives, including research and development, regulatory clearances, company strategy, medical education, and clinical investigations.

Nanox to Announce Zebra Medical Vision Secures 8th 510K FDA Clearance for its Coronary Artery Calcium (CAC) Solution as Part of Its Population Health Offering

On August 10th, 2021 Nanox announced that it had entered into an acquisition agreement via merger with Zebra Medical Vision LTD.

Christopher Joyce Joins Miach Orthopaedics as VP & CFO

Christopher Joyce has joined as vice president and chief financial officer, and Kevin Sidow has been appointed to the company’s board of directors.

NGMedical GmbH Receives FDA Clearance for Its AM Titanium Lumbar Interbody BEE® PLIF

The BEE® PLIF cage has been created to benefit from additive manufacturing features. The purposefully designed honeycomb endplate design reduces the risk of subsidence, while allowing fusion.

Recombinant Technologies is Raising Capital to Roll Out a Game Changing Alzheimer’s Treatment

Recombinant Technologies is focused on treating the root cause of Alzheimer's Disease delivering a huge improvement in the quality of life of those afflicted.

Tyber Medical Reaches Agreement to Acquire CatapultMD

Once the acquisition is complete, Tyber Medical will own and operate a combined 100,000-square feet of manufacturing space between its Pennsylvania headquarters and Florida-based facilities.

Kleiner Device Labs Receives FDA Market Clearance for KG2 Surge Flow-Thru Interbody System

The system maximizes total bone graft delivery volume, better distributes graft bilaterally into the intervertebral disc space, and streamlines the implant delivery, positioning, and grafting process for TLIF and PLIF spinal fusion procedures.

Matthew Cranfill New ExtriCARE USA Director Of Clinical Services

"Matt's impressive experience and skillset easily made him our top pick," said Peter Mason, President of ExtriCARE USA.

By using this website you agree to accept Medical Device News Magazine Privacy Policy